This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact The Epoch Times Reprints.
FDA Removing Pharmaceutical Representatives From Advisory Panels
The agency’s new commissioner announced the move.
Dr. Marty Makary, then the nominee to lead the Food and Drug Administration, testifies during a confirmation hearing before the Senate Committee on Health, Education, Labor, and Pensions on Capitol Hill in Washington on March 6, 2025. Madalina Vasiliu/The Epoch Times
The Food and Drug Administration (FDA) is removing pharmaceutical company representatives from advisory committees in a bid to limit industry influence.
Dr. Marty Makary, the FDA’s new commissioner, issued a directive that eliminates the role of pharmaceutical representative.
Zachary Stieber
Senior Reporter
Zachary Stieber is a senior reporter for The Epoch Times based in Maryland. He covers U.S. and world news. Contact Zachary at [email protected]
